Outpatient Administration of Bispecific Therapies in a Community Oncology Setting

Key Points

• Bispecific therapies may enhance treatment outcomes for cancer patients in outpatient settings.
• Over 70% of patients reported higher satisfaction with outpatient administration of therapies.
• Observational analysis focused on community oncology settings to assess treatment efficiency.
• Findings support expanded use of bispecific therapies in outpatient areas for better patient access.